iCo Therapeutics's earnings per share without non-recurring items for the
three
months ended in Sep. 2020 was $-0.01.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.03.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 2.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
During the past 13 years, iCo Therapeutics's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 58.80% per year. The lowest was -41.90% per year. And the median was 27.35% per year.
iCo Therapeutics's EPS (Diluted) for the
three
months ended in Sep. 2020 was $-0.01.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.02.
iCo Therapeutics's EPS (Basic) for the
three
months ended in Sep. 2020 was $-0.01.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.03.
iCo Therapeutics EPS without NRI Historical Data
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* Premium members only.
iCo Therapeutics Annual Data
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
EPS without NRI
-0.01
-0.01
-0.01
-0.01
-0.02
iCo Therapeutics Quarterly Data
Dec15
Mar16
Jun16
Sep16
Dec16
Mar17
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
EPS without NRI
-0.00
-0.01
-0.01
-0.01
-0.01
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.
iCo Therapeutics EPS without NRI Distribution
* The bar in red indicates where iCo Therapeutics's EPS without NRI falls into.
iCo Therapeutics EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and Non Operating Income need to subtracted from the total net income first.
EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2020 was -0.0075935910091882 (Dec. 2019 ) + -0.007163323782235 (Mar. 2020 ) + -0.0073789846517119 (Jun. 2020 ) + -0.0075585789871504 (Sep. 2020 ) = $-0.03
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
iCo Therapeutics (OTCPK:ICOTF) EPS without NRI Explanation
A Non Operating Income refers to an entry that appears on a company's financial statements that is unlikely to happen again. It represents a one-time expense involving an unpredictable event and is not part of a firm's normal, day-to-day operations.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
0.01(6.05%) Volume: 200,100 10:04AM EST
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP
OTCPK:ICOTF has been successfully added to your 
